Search

Displaying results 3581 - 3590 of 5392 in total
  1. Drug

    Sorbitan trioleate

    go.drugbank.com/drugs/DB21103
    Experimental

    Sorbitan trioleate has a monoisotopic molecular weight of 956.8 Da.

  2. Drug

    Bensuldazic acid

    go.drugbank.com/drugs/DB21135
    Experimental

    Bensuldazic acid has a monoisotopic molecular weight of 282.05 Da.

  3. Drug

    Amfonelic acid

    go.drugbank.com/drugs/DB21147
    Experimental

    Amfonelic acid has a monoisotopic molecular weight of 308.12 Da.

  4. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  5. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  6. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

  7. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  8. Drug

    Taberminogene vadenovec

    go.drugbank.com/drugs/DB05011
    Experimental

    Taberminogene vadenovec (EG004) is a novel product consisting of a local delivery device and a gene-based medicine, being developed to prevent the blocking of veins and arteries that frequently occurs after vascular surgery. The initial ...

  9. Drug

    Theobromine

    go.drugbank.com/drugs/DB01412
    Investigational

    Theobromine (3,7-dimethylxanthine) is the principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than theophyl...

  10. Drug

    DS-2325a

    go.drugbank.com/drugs/DB18134
    Investigational

    DS-2325a is an inhibitor of kallikrein 5 under development for the treatment of Netherton Syndrome.